Investment analysts at HC Wainwright cut their FY2026 earnings per share (EPS) estimates for Ekso Bionics in a research note ...

Q4 2024 Earnings Call Transcript March 3, 2025 Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.14 EPS, expectations were $-0.07. Operator: Greetings. And welcome to ...

Ekso Bionics Holdings Inc (EKSO) reports a 5% revenue increase and strategic alliances to enhance market access, despite challenges in reimbursement processes.

SAN RAFAEL, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ...

Ekso Bionics reports record Q4-2024 revenue of $5.1 million with improved gross margins and strategic distributor partnership. Ekso Bionics Holdings, Inc., a leader in exoskeleton technology ...

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology ...

Reports Q4 revenue $5.09M, consensus $5.05M. “We are pleased to close out 2024 with record fourth quarter revenue, improved gross margin and ...

Ekso Bionics has a 52-week low of $0.47 and a 52-week high of $2.16. The company has a market capitalization of $11.54 million, a PE ratio of -0.81 and a beta of 1.46. The company has a fifty day ...

Ekso Bionics Holdings Inc. (EKSO) on Monday reported a loss of $3.4 million in its fourth quarter. On a per-share basis, the San ...

SAN RAFAEL, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use ...

Greetings, and welcome to the Ekso Bionics Fourth Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will ...